Loading...
HomeMy WebLinkAbout2016-08-08 16-290 Council Documents (20) Methadone I SAMHSA Page 1 of 6 1110 Home Newsroom Site Map Contact Us Substance Abuse aid MentalHealth Denier AdenMWalloa X• SAMHSA Search SAMHSA.gov Search Connect with SAMHSA: Find Help & Topics Programs & Grants Data About Us Publications Treatment Campaigns Programs&Campaigns»Medication-Assisted Treatment»Medication S HA R E+ and Counseling Treatment»Methadone Medication- Methadone Assisted Treatment Methadone is a medication used in medication-assisted treatment (MAT) to help people reduce or quit their use of heroin or other Certification of opiates. Opioid Treatment Programs Buprenorphine What Is Methadone? Waiver Management Methadone has been used for decades to treat people who are • addicted to heroin and narcotic pain medicines. When taken as Oversight of prescribed, it is safe and effective. It allows people to recover from Accrediting their addiction and to reclaim active and meaningful lives. For optimal AcorAccr es results, patients should also participate in a comprehensive medication- assisted treatment (MAT) program that includes counseling and social support. Medication and Counseling Treatment How Does Methadone Work? Methadone works by changing how the brain and nervous system Buprenorphine respond to pain. It lessens the painful symptoms of opiate withdrawal and blocks the euphoric effects of opiate drugs such as heroin, Methadone morphine, and codeine, as well as semi-synthetic opioids like Naltrexone oxycodone and hydrocodone. Naloxone Methadone is offered in pill, liquid, and wafer forms and is taken once a day. Pain relief from a dose of methadone lasts about four to eight Opioid hours. SAMHSA's TIP 43: Medication-Assisted Treatment for Opioid Overdose Addiction in Opioid Treatment Programs—2008 shows that methadone Common is effective in higher doses, particularly for heroin users, helping them Comorbidities stay in treatment programs longer. Insurance and As with all medications used in medication-assisted treatment(MAT), Payments methadone is to be prescribed as part of a comprehensive treatment plan that includes counseling and participation in social support • Training Materials programs. and Resources http://www.samhsa.gov/medication-assisted-treatment/treatment/methadone 7/18/2016 Methadone I SAMHSA Page 2 of 6 Physician and How Can a Patient Receive Methadone? Program Data Patients taking methadone to treat opioid addiction must receive the • medication under the supervision of a physician. After a period of Legislation, stability (based on progress and proven, consistent compliance with the Regulations& medication dosage), patients may be allowed to take methadone at Guidelines home between program visits. By law, methadone can only be dispensed through an opioid treatment program (OTP) certified by About DPT SAMHSA. Buprenorphine The length of time in methadone treatment varies from person to Pharmacy person. According to the National Institute on Drug Abuse publication Lookup Principles of Drug Addiction Treatment: A Research-Based Guide— 2012, the length of methadone treatment should be a minimum of 12 months. Some patients may require treatment for years. Even if a MAT-PDOA patient feels that they are ready to stop methadone treatment, it must be stopped gradually to prevent withdrawal. Such a decision should be supervised by a doctor. Patients who develop a problem with methadone or have questions can access information through SAMHSA's Find Help. Learn more from the SAMHSA publication What Every Individual Needs to Know About Methadone Maintenance— 2006. Methadone Safety Methadone can be addictive, so it must be used exactly as prescribed. • This is particularly important for patients who are allowed to take methadone at home and aren't required to take medication under supervision at an OTP. Methadone medication is specifically tailored for the individual patient (as doses are often adjusted and readjusted) and is never to be shared with or given to others. Patients should share their complete health history with health providers to ensure the safe use of the medication. Other medications may interact with methadone and cause heart conditions. Even after the effects of methadone wear off, the medication's active ingredients remain in the body for much longer. Taking more methadone can cause unintentional overdose. The following tips can help achieve the best treatment results: • Never use more than the amount prescribed, and always take at the times prescribed. If a dose is missed, or if it feels like it's not working, do not take an extra dose of methadone. • Do not consume alcohol while taking methadone. • Be careful driving or operating machinery on methadone. • Call 911 if too much methadone is taken or if an overdose is suspected. • Take steps to prevent children from accidentally taking • methadone. http://www.samhsa.gov/medication-assisted-treatment/treatment/methadone 7/18/2016 Methadone I SAMHSA Page 3 of 6 • Store methadone at room temperature and away from light. • • Dispose of unused methadone by flushing it down the toilet. Learn more from the SAMHSA publication Follow Directions: How to Use Methadone Safely—2009 (also available in Spanish). Side Effects of Methadone Side effects should be taken seriously, as some of them may indicate an emergency. Patients should stop taking methadone and contact a doctor or emergency services right away if they: • Experience difficulty breathing or shallow breathing • Feel lightheaded or faint • Experience hives or a rash; swelling of the face, lips, tongue, or throat • Feel chest pain • Experience a fast or pounding heartbeat • Experience hallucinations or confusion Pregnant or Breastfeeding Women and Methadone Women who are pregnant or breastfeeding can safely take methadone. When withdrawal from an abused drug happens to a pregnant woman, it causes the uterus to contract and may bring on miscarriage or premature birth. Methadone's ability to prevent withdrawal symptoms helps pregnant women better manage their addiction while avoiding health risks to both mother and baby. Undergoing methadone maintenance treatment while pregnant will not cause birth defects, but some babies may go through withdrawal after birth. This does not mean that the baby is addicted. Infant withdrawal usually begins a few days after birth but may begin two to four weeks after birth. Mothers taking methadone can still breastfeed. Research has shown that the benefits of breastfeeding outweigh the effect of the small amount of methadone that enters the breast milk. A woman who is thinking of stopping methadone treatment due to breastfeeding or pregnancy concerns should speak with her doctor first. Learn more from the SAMHSA publication Methadone Treatment for Pregnant Women—2009. Training on Providing Methadone http://www.samhsa.gov/medication-assisted-treatment/treatmentlmethadone 7/18/2016 Methadone 1 SAMHSA Page 4 of 6 Methadone as an opioid use disorder treatment is carefully regulated. MAT services professionals are required to acquire and maintain II certifications to legally dispense and prescribe opioid dependency treatments. SAMHSA's Division of Pharmacologic Therapies (DPT) makes available opioid prescribing courses for physicians, webinars, workshops, and summits, and publications and research. Last Updated: 09/28/2015 0 PHYSICIAN LOCATOR fi 'y P1O113 TREATMENT ;:i" , 078' RD RAM DACTORY . III 'Q. , PHARMACY LCCKt1P New Federal Regulations Increase Limit Rule to 275 Patients Physicians who have prescribed buprenorphine to 100 patients for at least one year can now increase their patient limits to 275 under new federal regulations. Review the final rule in the Federal Register. The form to request the higher limit is not yet available. To receive the form and guidance information, contact the SAMHSA Center for Substance Abuse Treatment (CSAT) at info(abuprenorphine.samhsa.gov. Please include your contact III information, your data waiver number and patient limit, and a http://www.samhsa.gov/medication-assisted-treatment/treatment/methadone 7/18/2016 Methadone ( SAMHSA Page 5 of 6 statement affirming your 100 patient certification for at least one year. For more information, send an email or call 866-BUP-CSAT(866- 287-2728). Publications » 2014 Buprenorphine Summit: Report of Proceedings (PDF 13 MB) » Medication-Assisted Treatment for Opioid Addiction: Facts for Families and Friends—2009 » Federal Guidelines for Opioid Treatment Programs—2015 » Medication-Assisted Treatment of Alcohol Use Disorder— 2015 »TIP 40: Clinical Guidelines for the Use of Buprenorphine— 2004 Related SAMHSA Resources » Behavioral Health Treatments and Services » Medical Records Privacy and Confidentiality » Mental and Substance Use Disorders » Prescription Drug Misuse and Abuse Contact Us For information on buprenorphine treatment, contact the SAMHSA Center for Substance Abuse Treatment (CSAT) at 866-BUP-CSAT (866-287-2728) or info©buprenorphine.samhsa.gov. For information about other medication-assisted treatment(MAT) or the certification of opioid treatment programs (OTPs), contact • the SAMHSA Division of Pharmacologic Therapies at 240-276-2700 or otp-extranet@ opioid.samhsa.gov. http://www.samhsa.gov/medication-assisted-treatment/treatment/methadone 7/18/2016 Methadone I SAMHSA Page 6 of 6 Contact SAMHSA's regional OTP Compliance Officers to determine • if an OTP is qualified to provide treatment for substance use disorders. SAMHSA.gov Strategic About Us Homepage Initiatives Find Help Accessibility Health Publications Financing Privacy Newsroom Prevention Disclaimer Budget Treatment Viewers & Plugins Data Recovery FOIA Grants Other Plain Language — _-- Topics Grant _ Site Map Awards • SAMHSA Archive SAMHSA's mission is to reduce the impact of substance abuse and mental illness onr America's communities. _ _ 5600 Fishers Ln • Rockville, MD 20857 1-877-SAMHSA-7 (1-877-726-4727) • http://www.samhsa.gov/medication-assisted-treatment/treatment/methadone 7/18/2016